Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 664

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Amantadine in the Treatment of Parkinson's Disease

Schwab, Robert S.·1969·JAMA: The Journal of the American Medical Association

Abstract

Sixty-six percent of a group of 163 patients with Parkinson's disease exhibited subjective or objective improvement of their akinesia, rigidity, and tremor while receiving amantadine hydrochloride. Of those showing improvement, benefits were sustained in 58% for a period of three to eight months. The maximum daily dose was 200 mg. Side effects occurred in 22% and consisted of increased jitteriness, insomnia, abdominal uneasiness, dizziness, depression, confusion, and, in a few cases, hallucinations. Convulsions have been reported with large doses of 800 mg per day. In most cases, side effects were controlled by adjustment of dosage of [ill] hydrochloride or the patient's concomitant medication.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.1969.03160070046011

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 664

Metadata

Authors
Schwab, R. S.
Venue
JAMA: The Journal of the American Medical Association
Published
1969-05-19
Volume
208
Issue
7
Pages
1168
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2073486423
Cited by
664
References
3
FWCI
66.77
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amantadine in the Treatment of Parkinson's Disease. https://app.cochat.ai/papers/10.1001/jama.1969.03160070046011
The paper
Schwab, R. S. (1969). Amantadine in the Treatment of Parkinson's Disease. JAMA: The Journal of the American Medical Association. https://doi.org/10.1001/jama.1969.03160070046011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.